Researchers have provided more evidence that mpox virus can be passed from a pregnant mother to her child. There remain ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The Food and Drug Administration has approved a highly effective new HIV prevention medication, known as Yeztugo. In clinical ...

The Food and Drug Administration (FDA) approved an injectable medication to be used as an HIV prevention drug on Wednesday.

The FDA has approved a new, twice-yearly PrEP injection from pharmaceutical giant Gilead. The drug is lenacapavir. The ...

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move ...

What lingers in Kuenselphodrang these days isn’t just the echo of prayers from the recent month-long Nyingthig Yazhi oral ...

2. Symptomatic transmission was also lower with baloxavir, but the difference was not statistically significant. Evidence Rating Level: 1 (Excellent) Study Rundown: Influenza is a highly contagious ...

A new study published in The New England Journal of Medicine showed that a single dosage of the antiviral baloxavir marboxil (Xofluza) reduced the rate of influenza virus transmission to household ...

Approximately one-third of all influenza virus transmission occurs within households ... Xofluza is a first-in-class, single-dose oral medicine with an innovative mechanism of action designed ...

Detailed results from the CENTERSTONE trial show treatment with Xofluza reduced the odds of transmission, or spread of the influenza virus, from an infected person to household members by 32% 1 ...